Showing results (31-40 of 196) with videos related to
Sort By:
Pageof 20
Antimicrobial Agents and Chemotherapy|February 15, 2018
Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C VirusDarius Babusis, Michael P Curry, Brian Kirby, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 18, 2015
Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patientsEisuke Miyaki, Michio Imamura, Nobuhiko Hiraga, et al.Plos One|March 24, 2026
Association between diabetes mellitus and impaired single-leg stance in patients with chronic liver disease: A cross-sectional studyKenichi Fudeyasu, Makoto Asaeda, Toshihiro Kawae, et al.Journal of Gastroenterology|July 7, 2025
Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patientsShintaro Yamasaki, Takashi Nakahara, Masataka Tsuge, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2009
[A case of effective chemoradiotherapy using S-1 and CDDP for left inguinal lymph node metastasis of anal canal carcinoma]Yoshio Kuga, Tomotaka Tanaka, Michinori Arita, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 28, 2024
Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogsYuichi Hiyama, Hatsue Fujino, Maiko Namba, et al.European Journal of Gastroenterology & Hepatology|February 26, 2024
Impact of MAFLD criteria on postoperative recurrence of non-B, non-C HCCYusuke Johira, Takashi Nakahara, Kenji Yamaoka, et al.Viruses|November 27, 2024
Alteration of Gene Expression After Entecavir and Pegylated Interferon Therapy in HBV-Infected Chimeric Mouse LiverHuarui Bao, Serami Murakami, Masataka Tsuge, et al.Nucleosides, Nucleotides & Nucleic Acids|December 13, 2006
Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agentsByoung-Kwon Chun, Peiyuan Wang, Abdalla Hassan, et al.Antimicrobial Agents and Chemotherapy|November 15, 2007
The mechanism of action of beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymeraseEisuke Murakami, Congrong Niu, Haiying Bao, et al.Pageof 20